Symptoms of peritoneal tumors

summary

In our life, we often hear people say that if someone has advanced cancer, then these diseases seem very small, but they do great harm to people's health. Doctors open their stomachs and sew them directly. They have no cure. This may be true in the past, because in the past, palliative treatment was generally advocated for tumor patients with extensive abdominal metastasis, and even surgery was not very sure. Patients suffered from pain, and their survival time was only a few months. However, with the development of medicine, this so-called advanced cancer has a breakthrough treatment. So let's share the symptoms of the tumor.

Symptoms of peritoneal tumors

First of all, let's recognize the cancer of abdominal membrane. Most peritoneal carcinoma is metastatic carcinoma. Which tumor patients are easy to develop peritoneal carcinoma? Usually, gastric cancer, colorectal cancer, ovarian cancer, peritoneal pseudomyxoma, peritoneal malignant mesothelioma, primary peritoneal cancer and other abdominal and pelvic malignant tumors are prone to form peritoneal surface tumor, we call it peritoneal carcinomatosis (PC). This kind of disease is not uncommon in clinic. The invasion of gastric cancer into serosa often leads to PC. PC is present in 15% - 50% of patients at first diagnosis, and the main form of postoperative recurrence is PC in 35% - 50% of patients. About 10% of colorectal cancer patients found PC at the initial diagnosis, 4% - 19% of patients developed PC during the follow-up period after radical surgery, and 25% - 35% of patients with recurrence had PC as the only manifestation. The clinicopathological process of primary peritoneal carcinoma and peritoneal malignant mesothelioma is typical of PC. pseudomyxoma peritonei is rare, mostly from the appendix, and its clinicopathological process is also typical of PC.

Second, with the deepening of cancer research and the progress of treatment technology, the medical community's understanding of peritoneal cancer has undergone a fundamental change. At present, it has been included in local lesions rather than extensive metastasis.

Thirdly, a comprehensive treatment strategy based on cytoreductive surgery plus intra-operative and early postoperative intraperitoneal hyperthermic perfusion chemotherapy was established for this disease, which comprehensively utilized the effects of surgical resection, regional chemotherapy, hyperthermia and large volume liquid lavage. The cancer tissues in peritoneum and abdominal and pelvic cavity were removed by cytoreductive surgery, and then the residual microcarcinoma was removed by the synergistic effect of hyperthermic perfusion chemotherapy, In Europe, the United States and Asia Pacific region, some cancer treatment centers began to promote and become the most effective method for the treatment of peritoneal cancer.

matters needing attention

Therefore, when abdominal tumor patients find recurrence and abdominal metastasis, please do not give up. Now, CRS + HIPEC technology has brought hope for the treatment of advanced tumor patients.